Jones Financial Companies
IMVT icon

Jones Financial Companies’s Immunovant IMVT Stock Holding History

Jones Financial Companies’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5K Buy
1,481
+1,108
+297% +$28.7K ﹤0.01% 3072
2025
Q4 		$9.48K Buy
373
+320
+604% +$7.14K ﹤0.01% 3243
2025
Q3 		$860 Hold
53
– – ﹤0.01% 3932
2025
Q2 		$853 Buy
+53
New +$801 ﹤0.01% 3691

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jones Financial Companies's IMVT Position: Q1 2026 in Review

Jones Financial Companies increased its Immunovant (IMVT) stake by 297% in Q1 2026, buying an estimated $28.7K and bringing the position to 1,481 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

Jones Financial Companies first reported a position in IMVT in Q2 2025 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Jones Financial Companies held 1,481 shares of Immunovant worth $35.5K as of Q1 2026.
  • Jones Financial Companies bought 1,108 Immunovant shares in Q1 2026, an estimated $28.7K.
  • Immunovant made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3072 holding.
  • Jones Financial Companies first reported a position in Immunovant in Q2 2025 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.